Putative benzodiazepine partial agonists demonstrate receptor heterogeneity

Pharmacology Biochemistry and Behavior

Volumn 53, Issue 1, 1996, Pages 87-97

  Chen, Shu Wen ^a   Chen, Henry A ^a   Davies, M Frances ^a   Loew, Gilda H ^a  

^a MOLECULAR RESEARCH INSTITUTE   (United States)

Author keywords

Abecarnil; Anticonvulsant; Anxiolysis; Benzodiazepine; CGS8216; Hyperphagia; Hypother ia; Locomotor activity; Partial agonists; Ro16 6028; Ro23 0364; Ro23 1590; U78875

Indexed keywords

2 PHENYL 5H PYRAZOLO[4,3 C]QUINOLIN 3 ONE; ABECARNIL; BENZODIAZEPINE RECEPTOR; BENZODIAZEPINE RECEPTOR BLOCKING AGENT; BENZODIAZEPINE RECEPTOR INVERSE STIMULATING AGENT; BENZODIAZEPINE RECEPTOR STIMULATING AGENT; BRETAZENIL; FLUMAZENIL; FLUNITRAZEPAM; PANADIPLON; PARTIAL AGONIST; RECEPTOR SUBTYPE; RO 23 0364; RO 23 1590; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTICONVULSANT ACTIVITY; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DOSE RESPONSE; HYPERPHAGIA; HYPOTHERMIA; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SEDATION; TRANQUILIZING ACTIVITY;

EID: 0029874887     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/0091-3057(95)00204-9     Document Type: Article

References (30)

1. Anderson, C.; Sullivan, J. W.; Boff, E.; Horst, D.; Furman, S.; Pietrusiak, N.; Zavatsky, E.; Keim, K.; Gold, L.; Sepinwall, J. A preclinical evaluation of a novel anxiolytic phenylquinoline derivative (Ro23-1590) in anticonvulsant and CNS sedative depressant test procedures. Soc. Neurosci. Abstr. 12:661; 1986.
2. Bautz, G.; Spirt, N. M.; Mangano, R. M.; O'Brien, R. A.; Horst, W. D. Ro23-1590: Just another ligand for the benzodiazepine receptor? Soc. Neurosci. Abstr. 12:662; 1986.
3. A receptor subtypes: Ligand binding heterogeneity demonstrated by photoaffinity labeling and autoradiography. J. Neurochem. 61:1479-1491; 1993.
4. Chen, S.-W.; Davies, M. F.; Loew, G. H. Food palatability and hunger modified effects of CGS9896 and CGS8216 on food intake. Pharmacol. Biochem. Behav. 51:499-503; 1995.
5. Cooper, S. J. Benzodiazepine receptor-mediated enhancement and inhibition of taste reactivity, food choice, and intake. Ann. NY Acad. Sci. 575:321-336; 1989.
6. Cooper, S. J.; Greenwood, S. E. The beta-carboline abecarnil, a novel agonist at central benzodiazepine receptors, influences saccharin and salt taste preferences in the rats. Brain Res. 599: 144-147; 1992.
7. Davies, M. F.; Onaivi, E. S.; Chen, S.-W.; Maguire, P. A.; Tsai, N. F.; Loew, G. H. Evidence for central benzodiazepine receptor heterogeneity from behavior tests. Pharmacol. Biochem. Behav. 49:47-56; 1994.
8. Facklam, M.; Schoch, P.; Haefely, W. E. Relationship between benzodiazepine receptor occupancy and potentiation of γ-aminobutyric acid-stimulated chloride flux in vitro of four ligands of differing intrinsic efficacies. J. Pharmacol. Exp. Ther. 261:1106-1112; 1992.
9. Gardner, C. R. Interpretation of the behavioral effects of benzodiazepine receptor ligands. Drug Future 14:51-67; 1989.
10. Haefely, W. E.; Facklam, M.; Schoch, P.; Martin, J. R.; Bonetti, E. P.; Moreau, J. L.; Jenck, F.; Richards, G. Partial agonists of benzodiazepine receptors for the treatment of epilepsy, sleep, and anxiety disorder. Adv. Biochem. Psychopharmacol. 47:379-394; 1992.
11. Haefely, W. E.; Martin, J. R.; Richards, G.; Schoch, P. The multiplicity of actions of benzodiazepine receptor ligands. Can. J. Psychiatry 38(Suppl 4):S102-S107; 1993.
12. Haefely, W. E.; Martin, J. R.; Schoch, P. Novel anxiolytic that act as partial agonists at benzodiazepine receptors. Trend Pharmacol. Sci. 11:452-456, 1990.
13. Jackson, H. C.; Nutt, D. J. Body temperature discriminates between full and partial benzodiazepine receptor agonists. Eur. J. Pharmacol. 185:243-246; 1990.
14. Jones, G. H.; Schneider, C.; Schneider, H. H.; Seidler, J.; Cole, B. J.; Stephens, D. N. Comparison of several benzodiazepine receptor ligands in two models of anxiolytic activity in the mouse: An analysis based on fractional receptor occupancies. Psychopharmacology 114:191-199; 1994.
15. Klepner, C. A.; Lippa, A. S.; Benson, D. I.; Sano, M. C.; Beer. B. Resolution of two biochemically and pharmacologically distinct benzodazepine receptors. Pharmacol. Biochem. Behav. 11: 457-462; 1979.
16. A receptor subtypes. J. Pharmacol. Exp. Ther. 266:385-391; 1993.
17. A receptor heterogeneity. Nature 335:76-79; 1988.
18. Maguire, P. A.; Mechanick, J. I.; Davies, M. F.; Ellis, D. M.; Meredith, D. B.; Loew, G. H. Resolving receptor heterogeneity using Fourier-derived affinity spectrum analysis (FASA) and LIGAND: Benzodiazepine receptors in the rat spinal cord. J. Pharmacol. Exp. Ther. 237:842-849; 1995.
19. Mangano, R. M.; Bautz, G.; Spirt, N. M.; O'Brien, R. A.; Horst, W. D. Benzodiazepine interactions of a new potential anxiolytic, Ro23-0364. Soc. Neurosci. Abstr. 12:661; 1986.
20. A receptor subtypes immunopurified from rat brain with α-subunit-specific antibodies have unique pharmacological properties. Neuron 7:667-676; 1991.
21. A receptor populations with novel subunit combinations and drug binding profiles identifies in brain by α5- and δ-subunit-specific immunopurification. J. Biol. Chem. 268:5965-5973; 1993.
22. - currents. Mol. Pharmacol. 39:691-696; 1991.
23. Spinwall, J.; Sullivan, J. W.; Glinka, S.; Gold, L.; Boff, E.; Gamzu, E.; Keim, K.; Pietrusiak, N.; Smart, T. Assessment of the anxiolytic properties of a novel benzodiazepine derivative (Ro23-0364) with mixed agonist/antagonist profile. Soc. Neurosci. Abstr. 12:661; 1986.
24. Stephens, D. N.; Turski, L.; Hillman, M.; Turner, J. D.; Schneider, H. H.; Yamaguchi, M. What are the differences between abecarnil and conventional benzodiazepine anxiolytics? Adv. Biochem. Psychopharmacol. 47:395-405; 1992.
25. Sullivan, J. W.; Gold, L.; Cumin, H. Preclinical evaluation of a novel phenyquinoline anxiolytic (Ro23-1590) in neuropharmacologic and anticonflict test procedures. Soc. Neurosci. Abstr. 12: 661; 1986.
26. Tang, A. H.; Code, R. A.; Himes, C. S. Antagonism of hypothermia produced by benzodiazepine-related compounds U78875 in mice. Eur. J. Pharmacol. 236:1-5; 1993.
27. Tang, A. H.; Franklin, S. R.; Himes, C. S.; Ho, P. M. Behavioral effects of U78875, a quinoxalinone anxiolytic with potent benzodiazepine antagonist activity. J. Pharmacol. Exp. Ther. 259:248-50; 1991.
28. Villar, H. O.; Uyeno, E. T.; Toll, L.; Polgar, W.; Davies, M. F.; Loew, G. H. Molecular determinants of benzodiazepine receptor affinities and anticonvulsant activities. Mol. Pharmacol. 36:589-600; 1989.
29. Yerbury, R. E.; Cooper, S. J. The benzodiazepine partial agonists, Ro16-6028 and Ro17-1812, increase palatable food consumption in nondeprived rats. Pharmacol. Biochem. Behav. 28: 427-431; 1987.
30. Yerbury, R. E.; Cooper, S. J. Novel benzodiazepine receptor ligands: Palatable food intake following zolpidem, CGS17867A, or Ro23-0364, in rats. Pharmacol. Biochem. Behav. 33:303-307; 1989.